Episode 461: WINS OF CHANGE
Échec de l'ajout au panier.
Veuillez réessayer plus tard
Échec de l'ajout à la liste d'envies.
Veuillez réessayer plus tard
Échec de la suppression de la liste d’envies.
Veuillez réessayer plus tard
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
Then, we examine Moderna’s announcement that it is halting new Phase 3 vaccine trials, citing reduced market incentives under increased federal oversight. What does this decision reveal about safety testing, accountability, and public health priorities?
Also, a deep dive into the UK’s newly announced AI surveillance system — described by officials as a “panopticon.” We unpack the origins of the term and what it signals about the future of mass surveillance.
Plus, as fraud investigations rock Minnesota, autism education providers are facing devastating funding cuts. Jennifer Larson of Holland Center joins Del to explain how legitimate, long-standing programs are now at risk — and how families are paying the price.
Guest: Jennifer Larson
Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.
Pas encore de commentaire